Atlas Trials

Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.

Clinical trial NCT03059160 · UNKNOWN

Trial details

NCT number
NCT03059160
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Rett Syndrome
Start date
2017-04-01
Primary completion
2018-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.